These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28165371)

  • 1. Protection against Shiga Toxins.
    Kavaliauskiene S; Dyve Lingelem AB; Skotland T; Sandvig K
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28165371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
    Liu Y; Tian S; Thaker H; Dong M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy.
    Li D; Selyunin A; Mukhopadhyay S
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL; Walker KE; Gille T; Koerner TA
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Biology of
    Menge C
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.
    O'Loughlin EV; Robins-Browne RM
    Microbes Infect; 2001 May; 3(6):493-507. PubMed ID: 11377211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Shiga and Shiga-like toxins].
    Ciudin L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1990; 35(1):1-16. PubMed ID: 2173117
    [No Abstract]   [Full Text] [Related]  

  • 9. Shiga toxins: from structure and mechanism to applications.
    Chan YS; Ng TB
    Appl Microbiol Biotechnol; 2016 Feb; 100(4):1597-1610. PubMed ID: 26685676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.
    Lee MS; Kim MH; Tesh VL
    J Microbiol; 2013 Dec; 51(6):724-30. PubMed ID: 24385347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin--an expanding role in the pathogenesis of infectious diseases.
    Cantey JR
    J Infect Dis; 1985 May; 151(5):766-71. PubMed ID: 3886803
    [No Abstract]   [Full Text] [Related]  

  • 13. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.
    O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT
    Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134
    [No Abstract]   [Full Text] [Related]  

  • 14. Shiga toxins.
    Bergan J; Dyve Lingelem AB; Simm R; Skotland T; Sandvig K
    Toxicon; 2012 Nov; 60(6):1085-107. PubMed ID: 22960449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ether lipid precursor hexadecylglycerol protects against Shiga toxins.
    Bergan J; Skotland T; Lingelem AB; Simm R; Spilsberg B; Lindbäck T; Sylvänne T; Simolin H; Ekroos K; Sandvig K
    Cell Mol Life Sci; 2014 Nov; 71(21):4285-300. PubMed ID: 24740796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
    Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin and its use in targeted cancer therapy and imaging.
    Engedal N; Skotland T; Torgersen ML; Sandvig K
    Microb Biotechnol; 2011 Jan; 4(1):32-46. PubMed ID: 21255370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin induces membrane reorganization and formation of long range lipid order.
    Solovyeva V; Johannes L; Simonsen AC
    Soft Matter; 2015 Jan; 11(1):186-92. PubMed ID: 25376469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxins--from cell biology to biomedical applications.
    Johannes L; Römer W
    Nat Rev Microbiol; 2010 Feb; 8(2):105-16. PubMed ID: 20023663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.